FDA Inspection 741276 — AstraZeneca Pharmaceuticals LP

AstraZeneca Pharmaceuticals LP — FEI 1825662

The FDA completed an inspection of AstraZeneca Pharmaceuticals LP on August 12, 2011 in Mount Vernon, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 12, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Mount Vernon, IN (United States)